Professor Giuseppe Mancia receives the Excellence Research Award of the Council on Hypertension of the American Heart Association

The European Society of Hypertension congratulates Professor Giuseppe Mancia, Milan (Italy) who is the recipient of the 2020 Excellence Research Award of the Council on Hypertension of the American Heart Association (AHA). The award was delivered to Professor Mancia on September 11 during the Award Session of the Virtual Hypertension Scientific Sessions 2020 of the Council on Hypertension of the American Heart Association. Professor Mancia presented his award lecture on ‘White coat hypertension: pathophysiological and clinical aspects’.

Congratulations Professor Mancia on this prestigious award.

Giuseppe Mancia is Professor Emeritus of the University Milan-Bicocca and President of the Foundation of the European Society of Hypertension. He trained at the University of Siena, Medical School, where he graduated in 1964 cum laude. He obtained the Ph.D. (Libera Docenza) in Physiology in 1970 and worked as Post-graduate Fellow of the US Public Health Service and Associate Researcher at the Mayo Clinic 1972–1974. Giuseppe Mancia has worked in the University of Milan and Milan-Bicocca from 1969 to his retirement in 2012, since 1985 as full Professor of Internal Medicine. He has been Head of the Division of Internal Medicine, Chairman of the University and Hospital Departments of Clinical Medicine (S. Gerardo Hospital, Monza) and Director of several Postgraduate Schools of Medicine (Cardiology, Internal Medicine, Emergency Medicine and Endocrinology). He has chaired the Interuniversity (Universities of Milan, Milan-Bicocca and Pavia) Centre of Clinical Physiology and Hypertension from 2001 to 2012. Mancia has served as President of the International Society of Hypertension (ISH), the European Society of Hypertension (ESH), the Italian Society of Hypertension and the European Society of Clinical Investigation. He has been chair of the Working Group on Hypertension and the Heart of the European Society of Cardiology (ESC). He has co-chaired the Task Force on the ESH-ESC Hypertension Guidelines from 2013 to 2018, and has been the Chair, Honorary Chair or Organiser of various ESH and ISH Meetings. Giuseppe Mancia is currently the ESH Executive officer for educational activities and has received several prestigious awards. His main research interests focus on epidemiology, pathophysiology, diagnosis and treatment of hypertension, heart failure, and coronary disease, as well as on the clinical aspects of diabetes, obesity and other metabolic abnormalities. His expertise includes ambulatory blood pressure monitoring, neuro-humoral control of the circulation, large artery mechanics, hemodynamic changes of cardiovascular drugs as well as epidemiology and intervention trials in hypertension and diabetes. He has been member or chair of the steering committees or data monitoring board of several clinical trials. He has published more than 2000 original articles, including a very recent important paper on the use of Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 [1], reviews and editorials, and edited many books and supplements to international cardiovascular journals on hypertension and cardiovascular diseases. Mancia is Editor-in-chief of the Journal of Hypertension. He is on the list of the ‘highly cited’ scientists issued by Thompson Reuters and Clarivate Analytics. Mancia’s publications have received, up to October 2018, about 190,000 citations in the international medical literature, with H-index of 162.

Reinhold Kreutz
ESH President, Department of Clinical Pharmacology and
Toxicology, Charité University Medicine, Berlin, Germany
[email protected]

Disclosure statement

RK reports no conflict of interest related to this report.